curacle co.,ltd. (KOSDAQ:365270)
South Korea · Delayed Price · Currency is KRW 9,570.00
+350.00 (3.80%)
At close: Sep 23, 2026
curacle co.,ltd. Market Cap
curacle co.,ltd. has a market cap or net worth of 212.04 billion as of September 25, 2026. Its market cap has increased by 67.38% in one year.
Market Cap
212.04B
Enterprise Value
200.19B
Revenue
8.24B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,570.00
ChartMarket Cap Chart
Since July 22, 2021, curacle co.,ltd.'s market cap has decreased from 409.36B to 212.04B, a decrease of -48.20%. That is a compound annual growth rate of -11.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 212.04B | 41.55% |
| Dec 30, 2025 | 149.80B | 79.35% |
| Dec 30, 2024 | 83.52B | -48.17% |
| Dec 28, 2023 | 161.14B | 2.54% |
| Dec 29, 2022 | 157.15B | -49.31% |
| Dec 30, 2021 | 310.02B | -24.27% |
| Jul 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IntoCell | 262.58B |
| IMBiologics | 262.16B |
| HansBiomed | 253.57B |
| Genome & Company | 252.87B |
| S.Biomedics | 249.56B |
| Kangstem Biotech | 193.75B |
| NIBEC | 173.70B |
| Bio Solution | 164.89B |